Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-02-15 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MORIERES-LES-AVIGNON (84310), Vaucluse
PHARMACIE DE L'OLIVIER : revenue, balance sheet and financial ratios
PHARMACIE DE L'OLIVIER is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MORIERES-LES-AVIGNON (84310),
this company of category PME
shows in 2017 a revenue of 2.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'OLIVIER (SIREN 520258195)
Indicator
2018
2017
2016
Revenue
N/C
2 769 920 €
2 624 867 €
Net income
211 541 €
198 826 €
224 722 €
EBITDA
N/C
277 906 €
337 651 €
Net margin
N/C
7.2%
8.6%
Revenue and income statement
In 2018, PHARMACIE DE L'OLIVIER generates positive net income of 212 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2018: 225 k€ -> 212 k€.
Net income (2018)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
211 541 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2018)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.177%
Financial autonomy (2018)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.496%
Asset age ratio (2018)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'OLIVIER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
Debt ratio
82.578
57.443
42.177
Financial autonomy
46.62
53.816
59.496
Repayment capacity
3.874
4.019
None
Cash flow / Revenue
8.077%
6.155%
None%
Sector positioning
Debt ratio
42.182018
2016
2017
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Good-11 pts over 3 years
In 2018, the debt ratio of PHARMACIE DE L'OLIVIER (42.18) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.5%2018
2016
2017
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Excellent+6 pts over 3 years
In 2018, the financial autonomy of PHARMACIE DE L'OLIVIER (59.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
4.02 years2017
2016
2017
Q1: 2.26 years
Med: 5.89 years
Q3: 10.41 years
Good
In 2017, the repayment capacity of PHARMACIE DE L'OLIVIER (4.02) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 216.07. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2018)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
216.072
Liquidity indicators evolution PHARMACIE DE L'OLIVIER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
Liquidity ratio
170.499
179.636
216.072
Interest coverage
7.457
7.314
None
Sector positioning
Liquidity ratio
216.072018
2016
2017
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Good+15 pts over 3 years
In 2018, the liquidity ratio of PHARMACIE DE L'OLIVIER (216.07) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
7.31x2017
2016
2017
Q1: 2.82x
Med: 8.19x
Q3: 15.34x
Average+10 pts over 2 years
In 2017, the interest coverage of PHARMACIE DE L'OLIVIER (7.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 64 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 767 days. Excellent situation: suppliers finance 703 days of the operating cycle (retail model).
Operating WCR (2018)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2018)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
64 j
Supplier credit (2018)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
767 j
Inventory turnover (2018)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE L'OLIVIER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
Operating WCR
187 573 €
207 024 €
0 €
Inventory turnover (days)
32
31
0
Customer payment term (days)
4
3
64
Supplier payment term (days)
45
44
767
Positioning of PHARMACIE DE L'OLIVIER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 177 transactions of similar company sales
in 2018,
the value of PHARMACIE DE L'OLIVIER is estimated at
2 663 490 €
(range 1 985 128€ - 4 380 819€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2018
177 transactions
1985k€2663k€4380k€
2 663 490 €Range: 1 985 128€ - 4 380 819€
NAF 5 année 2018
Valuation method used
Net Income Multiple
211 541 €
×
12.6x
=2 663 490 €
Range: 1 985 129€ - 4 380 819€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'OLIVIER with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'OLIVIER
What is the revenue of PHARMACIE DE L'OLIVIER ?
The revenue of PHARMACIE DE L'OLIVIER in 2017 is 2.8 M€.
Is PHARMACIE DE L'OLIVIER profitable?
Yes, PHARMACIE DE L'OLIVIER generated a net profit of 212 k€ in 2018.
Where is the headquarters of PHARMACIE DE L'OLIVIER ?
The headquarters of PHARMACIE DE L'OLIVIER is located in MORIERES-LES-AVIGNON (84310), in the department Vaucluse.
Where to find the tax return of PHARMACIE DE L'OLIVIER ?
The tax return of PHARMACIE DE L'OLIVIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'OLIVIER operate?
PHARMACIE DE L'OLIVIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart